Thermo Fisher Scientific Opens East Coast Advanced Therapies Collaboration Center to Accelerate Cell and Gene Therapy Development
Key Insights
Thermo Fisher Scientific (search) opened its second Advanced Therapies Collaboration Center (ATxCC) in Philadelphia, expanding its nationwide network supporting cell and gene therapy (search) innovation.
The new facility is located within BioLabs (search) for Advanced Therapeutics Philadelphia, a 53,000-square-foot biotech incubator, providing startups and biopharma organizations access to expert scientists and advanced process development technologies.
The center aims to help innovators overcome critical hurdles in developing cell and gene therapies by supporting their progression from early research to clinical readiness.
Thermo Fisher Scientific (search) has opened its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in Philadelphia, marking a significant expansion of the company's nationwide infrastructure supporting cell and gene therapy (search) development. The new facility represents the company's second ATxCC in the United States, following the establishment of its Carlsbad, California site.
Strategic Partnership with BioLabs
The Philadelphia ATxCC is strategically located within BioLabs (search) for Advanced Therapeutics Philadelphia, a newly expanded 53,000-square-foot biotech incubator in the heart of the city. This partnership provides emerging startups and biopharma organizations with direct access to Thermo Fisher's expert scientists, advanced process development technologies, and collaboration opportunities.
"We're proud to expand our network-wide partnership with Thermo Fisher Scientific (search) through this unique offering," said Johannes Fruehauf, PhD, MD, Founder and CEO of BioLabs (search). "By embedding the ATxCC within the BioLabs community, we are creating a uniquely rich and accessible resource for founders and startup teams working on groundbreaking therapies in Philadelphia."
Addressing Critical Development Challenges
The new center is designed to address the growing demand for scalable, innovative solutions in advanced therapeutics development. Nicole Brockway, president of biosciences at Thermo Fisher Scientific (search), emphasized the facility's role in overcoming development hurdles.
"Our new Advanced Therapies Collaboration Center in Philadelphia is designed to help innovators overcome critical hurdles in developing cell and gene therapies," Brockway stated. "This center will play a key role in supporting customers as they progress from the lab to the clinic and, most importantly, bring transformative therapies to patients faster."
Expanding Access to Advanced Technologies
The facility will offer game-changing access to high-end technologies not only for BioLabs (search) members but also to external high-potential biotechs from across the East Coast and internationally. The center provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Supporting the Future of Medicine
Advanced therapies represent one of the most promising frontiers in modern medicine, offering the potential to treat and even cure diseases once considered untreatable. The opening of Thermo Fisher's new East Coast center highlights the company's ongoing investment in enabling these breakthroughs and advancing the future of healthcare.
The expansion comes as demand for cell and gene therapies continues to grow, with these treatments providing critical resources to biotech, biopharma, and translational researchers developing next-generation cell-based immunotherapies (search). Together with the California facility, these centers form a comprehensive network supporting innovation across the United States.